RKDA Earnings Prediction
The chart below shows how RKDA performed 10 days before and after its earnings report, based on data from the past quarters. Typically, RKDA sees a +4.97% change in stock price 10 days leading up to the earnings, and a +3.13% change 10 days following the report. On the earnings day itself, the stock moves by +0.79%. This data can give you a slight idea of what to expect for the next quarter's release.
RKDA Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
1.54M
18.41%
17.69%
Gross Margin
42.88%
-23.96%
-16.79%
Operating Margin
-104.49%
18.46%
-32.44%
Net Margin
-76.90%
56.21%
-154.29%
EPS
-1.18
-37.57%
-251.28%
No Data Available
RKDA Earnings Analysis
Arcadia Biosciences, Inc. Corporation (RKDA.O) Earnings Conference Call
Positive
Coconut Water Sales Surge: 1. Revenue Growth: Total revenues increased by 18% year-over-year, reaching approximately $1.5 million, driven by a 55% increase in Zola Coconut Water sales.
Retail Store Expansion: 2. Zola Distribution Expansion: Zola's retail store count grew by 68% compared to the same period last year, marking the largest quarterly distribution gain in the company's history.
Sell-Through Performance Surge: 3. Strong Sell-Through Performance: Zola's sell-through, as measured by scan data, increased by more than 36% year-over-year, indicating robust end customer demand for the product.
Cash Burn Reduction: 4. Reduced Cash Burn: The company's cash used during the quarter declined to $1.5 million, the lowest level of cash used in a quarter since going public, despite including over $400,000 related to discontinued operations.
Market Share Expansion: 5. Market Share Gains: Zola outpaced the coconut water category growth, achieving a 23% increase over the last 52 weeks, compared to the category's 15% growth, demonstrating strong competitive positioning.
Negative
GLA Oil Sales Decline: 1. Declining GLA Oil Sales: Sales of GLA oil were approximately half of what they were in Q3 of last year, indicating a significant decline in this segment.
Rising Revenue Costs: 2. Increased Cost of Revenues: The total cost of revenues increased by about $200,000 or 26% compared to last year, which included a $150,000 write-down related to hemp and GoodWheat seed.
Rising Administrative Costs: 3. High Selling, General and Administrative Costs: Selling, general and administrative costs in Q3 were approximately $2.2 million, which included $380,000 of transition costs related to the sale of GoodWheat assets, representing a 20% increase in costs compared to last year.
Cash and Investments Decline: 4. Cash Decrease: Cash and short-term investments decreased to $6.6 million at the end of Q3 from $8.1 million at the end of Q2, reflecting a cash consumption of $1.5 million during the quarter.
Discontinued Operations Loss: 5. Loss from Discontinued Operations: The loss from discontinued operations was approximately $430,000, primarily due to termination costs and fees for remaining employees and vendors supporting the GoodWheat business.
RKDA FAQs
How does RKDA typically perform around its earnings report dates?
Is Arcadia Biosciences, Inc. (RKDA) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
RKDA Earning Call Sentiment
Arcadia Biosciences, Inc. (RKDA) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
RKDA.O
0.31%Positive
The earnings call presents a mixed picture. The company shows strong Zola sales growth and cost reduction initiatives, but faces challenges like lack of forward guidance and distribution uncertainties. While there's no shareholder return plan, the financials indicate cost increases and cash flow concerns. The Q&A session reveals some confidence in infrastructure but lacks clarity. Without a market cap, the prediction remains neutral as positive growth is offset by risks and uncertainties.
